While there are potential benefits, its important to consider the risks if youre thinking about a GLP-1 drug, especially if you have HS
Retatrutide , the triple agonist targeting GLP-1, GIP, and glucagon receptors, showed 24+ percent weight loss in phase 2 trials
While more research is needed (particularly in people without diabetes and over longer follow-up periods), these medications are reshaping conversations about obesity, cancer prevention, and survivorship
Avoid irritating products Fragrance, flavoring, menthol, camphor, or eucalyptus can irritate the lips and worsen dryness
The same protocol using a 15mg vial (7.5mg each) reconstituted with 2mL yields 7.5mg/mL concentration, requiring just 0.067mL per 500mcg dosebut that smaller draw volume introduces measurement error with standard 1mL insulin syringes, which are calibrated in 0.01mL increments
use within 28 days CJC-1295 (No DAC) 35.6-46.4 F (2-8 C)